Navigation Links
Novavax Reports Positive Preclinical Results for a Novel, Broadly Cross-Protective H5N1 Pandemic Influenza Virus-like Particle (VLP) Vaccine Candidate
Date:2/19/2009

s. This study suggests that Novavax's recombinant VLP technology may be utilized for development of a vaccine capable of inducing broad cross protection against a variety of strains with pandemic potential without the use of an adjuvant. "It is extremely important to identify a pre-pandemic vaccine candidate which is able to protect against different antigenic variants of H5N1 virus that are circulating broadly," said Dr. Honglin Chen.

H5N1 avian influenza viruses emerged in humans in Hong Kong in 1997 and have been associated with a mortality of 62% among confirmed cases according to a World Health Organization February 2009 report. Clades 2.1, 2.2, and 2.3 are genetically and antigenically distinct viruses that are circulating in wild birds and poultry worldwide and continue to be associated with human illness. "We believe that our recombinant VLP technology has the potential to be a powerful, new approach to develop broadly cross-protective vaccines. This approach may provide a viable strategy for pre-pandemic vaccination without an adjuvant and for stockpiling of vaccine to be utilized during the first wave of an influenza pandemic," said Dr. Rahul Singhvi, President and CEO of Novavax, Inc. Further studies of the new VLP will be conducted in ferrets and methods of inducing protection against even more divergent strains (e.g., against different HA types) will be explored.

About Novavax

Novavax, Inc. is a clinical-stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide using advanced proprietary virus-like particle (VLP) technology. The Company produces these VLP-based, potent, recombinant vaccines utilizing new and efficient manufacturing approaches. Additional information about Novavax is available at www.novavax.com and in the Company's various filings with the Securities and Exchange Com
'/>"/>

SOURCE Novavax, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Novavax CEO to Present at ACUMENBioFins 9th Annual Healthcare Conference
2. Novavax Reports Third Quarter 2007 Financial Results and Progress with Vaccine Development Programs
3. GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution
4. Novavax Announces Preclinical Results for Seasonal Influenza Vaccine Program
5. Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program
6. Novavax Reports Fourth Quarter and 2007 Year-End Financial Results
7. Novavax Reports Positive Results from Preclinical Studies of its VLP-based Trivalent Seasonal Influenza Vaccine Candidate
8. Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial
9. Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development
10. Novavax to Present Phase I/IIa Trial Data Results in an Investor Conference Call on August 26, 2008
11. Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a ... the pharmaceutical, biotechnology and medical device industries, with operations ... the United States , today announced that it ... after the New York Stock Exchange closes on Thursday, ... 14, 2015 Shanghai time). The earnings release will be ...
(Date:7/29/2015)... (NASDAQ: NBIX ) today announced its financial results for the ... the Company reported a net loss of $24.0 million, or $0.28 ... or $0.18 loss per share, for the same period in 2014. ... a net loss of $25.2 million, or $0.30 loss per share, ... per share, for the first half of last year. ...
(Date:7/29/2015)... 29, 2015 Sangamo BioSciences, Inc. (NASDAQ: ... its second quarter 2015 financial results after the market ... will be followed by a conference call at 5:00 ... via telephone and webcast. During the conference call, the ... other business matters. The conference call dial-in ...
Breaking Medicine Technology:WuXi PharmaTech Schedules Second-Quarter 2015 Earnings Release 2Neurocrine Biosciences Reports Second Quarter 2015 Results 2Neurocrine Biosciences Reports Second Quarter 2015 Results 3Neurocrine Biosciences Reports Second Quarter 2015 Results 4Neurocrine Biosciences Reports Second Quarter 2015 Results 5Neurocrine Biosciences Reports Second Quarter 2015 Results 6Neurocrine Biosciences Reports Second Quarter 2015 Results 7Neurocrine Biosciences Reports Second Quarter 2015 Results 8Neurocrine Biosciences Reports Second Quarter 2015 Results 9Sangamo BioSciences Announces Second Quarter 2015 Conference Call and Webcast 2
... shows that,polyunsaturated fatty acids (PUFAs), mainly the omega-3s ... function and total parenteral,nutrition (TPN). The June 2008 ... new findings in these areas., One study ... an omega-3 PUFA, and arachidonic acid, an omega-6 ...
... a,division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., announced today,that the ... pediatric,exclusivity for TOPAMAX(R) (topiramate), based on studies submitted ... to investigate the use of TOPAMAX,in pediatric patients ... seizures., In addition to granting pediatric exclusivity, ...
Cached Medicine Technology:Omega-3 Fatty Acids Critical to Infants, Mothers and the Seriously Ill 2FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months 2FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months 3
(Date:7/29/2015)... ... July 29, 2015 , ... ... for a five-year period, expiring November 30, 2019, during its recent meeting. , ... an application demonstrating the program’s compliance with the NCCA’s Standards for the Accreditation ...
(Date:7/29/2015)... ... ... This year, the threat of flooding is higher in many areas of North ... is not far behind. Paul Davis, a leading provider of property restoration services for ... Davis is regularly called on to handle these types of emergencies, although much of ...
(Date:7/29/2015)... ... ... According to the Miami Herald on July 18th acupuncture helps ... Acu-detox may begin taking off in the South Florida community as more detox centers ... is not a new practice, it is not widely used, but has yielded positive ...
(Date:7/29/2015)... Waukesha, WI (PRWEB) , ... July 29, 2015 ... ... area, Scott Campbell Agency has once again teamed up with Stillwaters Cancer Support ... patients and their families. Stillwaters provides individual and family counseling, support groups, workshops ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... Orthopedic surgeons ... now offer the Rotation Medical Rotator Cuff System, a new implant to treat a ... is designed to foster natural regeneration of additional tendon tissue, which could allow for ...
Breaking Medicine News(10 mins):Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 2Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 3Health News:Paul Davis Offers Tips to Minimize Property Damage and Health Risks This Flood Season 2Health News:Paul Davis Offers Tips to Minimize Property Damage and Health Risks This Flood Season 3Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 2Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 3Health News:Scott Campbell Agency and Nonprofit Stillwaters Cancer Support Services Initiate New Charity Campaign in Waukesha, WI to Provide Help for People Touched by Cancer 2Health News:Scott Campbell Agency and Nonprofit Stillwaters Cancer Support Services Initiate New Charity Campaign in Waukesha, WI to Provide Help for People Touched by Cancer 3Health News:Lourdes Orthopedics First in NJ to Offer Bioinductive Implant for Rotator Cuff Repair 2Health News:Lourdes Orthopedics First in NJ to Offer Bioinductive Implant for Rotator Cuff Repair 3
... development of a digital screening device it says ... the third most common cancer in Australia. Victor ... terms of its ability to diagnose melanomas, it ... diagnostic software for SolarScan, which has been under ...
... France observed in a study that red wine drinkers ... "good" cholesterol. This helps show some light on why ... disease. // ,Researchers compared HDL cholesterol levels between ... who are regular drinkers and those who are heavy ...
... Researchers at the University of Michigan, made a new ... help patients after head and neck surgery. Ann Arbor say ... transfers.Patients who have surgery// to remove cancer in and around ... performed. ,Doctors say about 15 percent of patients develop ...
... able to differentiate those who will get Alzheimer's disease from ... older people - so we can expect an increase in ... now available and they seem to work best if they ... ,Researchers at the University of Toronto have been analysing ...
... University of Illinois, confirmed that a compound modelled on ... breast cancer. Previous research has suggested that sulforaphane,// which ... cancer. It does so by increasing the level of ... sulforaphane are toxic to cells so it may not ...
... to a new study, it is found that antioxidant treatment ... disease. Peripheral artery disease is a narrowing of the arteries ... 5 million to 10 million people in the United States ... the major signs of the condition is leg pain as ...
Cached Medicine News:Health News:Latest device for identifying Melanomas 2
Mcintyre straight lachrymal cannula, closed end, two side ports at 0.3 mm, straight shaft....
McIntyre lacrimal cannula, dual 0.3 mm side ports, straight....
Lacrimal cannula, malleable tip, straight....
Button Tip Manipulator, 0.50 mm diameter button tip, angled 45 degrees, 15 mm from tip to bend....
Medicine Products: